Trevena announced collaboration with Imperial College London to evaluate TRV027 in COVID-19 patients
On Jun. 2, 2020, Trevena announced it had entered into a collaboration with Imperial College London to evaluate…
-
-
PathGroup announced new COVID-19 testing option
On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a…
-
Resverlogix announced COVID-19 clinical trial program launch
On Jun. 1, 2020, Resverlogix announced that it is moving forward with a plan to further evaluate apabetaloneﾒs…
-
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
-
The US Dept of Defense launched effort to collect COVID-19 convalescent plasma
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
-
Gilead announced results from phase 3 trial of Remdesivir in patients with moderate COVID-19
On Jun. 1, 2020, Gilead Sciences announced topline results from the Phase 3 SIMPLE trial in hospitalized patients…
-
Emergent BioSolutions joined U.S. Government’s Warp Speed Program for COVID-19 vaccine development and manufacturing
On Jun. 1, 2020, Emergent BioSolutions announced it had been issued a task order under an existing contract…
-
Anixa Biosciences and OntoChem synthesized four potential Covid-19 drugs for testing in biological assays
On Jun. 1, 2020, Anixa Biosciences and OntoChem announced they had synthesized four potential Covid-19 compounds that will…
-
Eli Lilly began world’s first study of a potential COVID-19 antibody treatment in humans
On Jun. 1, 2020, Eli Lilly announced patients had been dosed in the world’s first study of a…
-
Proteostasis Therapeutics announced in vitro data for PTI-129 as potential treatment candidate for COVID-19
On Jun. 1, 2020, Proteostasis Therapeutics announced results from in vitro studies evaluating the use of PTI-129 as…
-
FDA issued Emergency Use Authorization for Impella RP as therapy for COVID-19 patients with right heart failure
On Jun. 1, 2020, the FDA issued an emergency use authorization (EUA) for Impella RP to include patients…
-
Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
-
LabCorp launched new COVID-19 clinical trial site to connect patients with US research trials
On Jun. 1, 2020, LabCorpﾮ announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
-
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…
-
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be Manufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
-
The FDA streamlined development of tests with at-home sample collection
On May 29, 2020, the FDA took steps to further support the development of COVID-19 tests for at-home…
-
Oxford Foundry announced four new innovations for COVID-19 recovery
On May 29, 2020, the Oxford Foundry announced support of four new innovative solutions for the OXFO COVID-19…
-
CIRM board approved three projects targeting COVID-19
On May 29, 2020, the California Institute for Regenerative Medicine (CIRM) approved investments in three early-stage research programs…
-
International community rallied to support open research and science to fight COVID-19
On May 29, 2020, the World Health Organization (WHO) announced that thirty countries and multiple international partners and…
-
GSK announced intention to produce 1 billion doses of pandemic vaccine adjuvant in 2021 to support multiple COVID-19 vaccine collaborations
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
-
The US Dept of Veterans Affairs conducted deep-dive study into effects of COVID-19 on Veterans
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
-
FDA authorized Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for emergency use
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for…
-
Roche initiated phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
-
Atossa Therapeutics announced second COVID-19 therapeutic development program, AT-301 nasal spray
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
-
Novavax expanded large-scale global manufacturing capacity
On May 27, 2020, Novavax announced the acquisition of Praha Vaccines, part of the Cyrus Poonawalla Group, in…
-
Heat Biologics announced collaboration with Waisman Biomanufacturing to manufacture COVID-19 vaccine
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
-
Quest Diagnostics launched COVID-19 workforce testing services to help organizations in fostering safer workplaces
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
-
Dementia gene raises risk of severe COVID-19
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
-
Merck and Ridgeback Bio announced collaboration to advance development of novel antiviral candidate, EIDD-2801
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
-
Innovation Pharma receives data from public health research institute showing brilacidin inhibits SARS-CoV-2 (COVID-19) in human cell line
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
